Chris Sterzinger,Cara Ferreira,David Leyh,Richard Thorn
申请号：
US14517276
公开号：
US09757483B2
申请日:
2014.10.17
申请国别(地区):
US
年份:
2017
代理人:
摘要：
A diagnostic formulation is provided comprising a tropane having a radioactive concentration of at least 1.6 mCi/mL at least about 51 hours post creation. The diagnostic formulation optionally comprises a radiolabeled dopamine transporter (DAT) ligand useful in the diagnosis of Parkinsons disease (PS). One example of a radiolabeled dopamine transporter (DAT) ligand example is [123I]-2β-carbomethoxy-3β-(4-flurophenyl)-N-(3-iodo-E-allyl) nortropane.
